| 摘要 |
Pseudophrynamine A and N-methyl tryptamine derivatives thereof of formula (I), the processes for the preparation thereof and pharmaceutical compositions containing them, for the treatment of pathologies of central nervous system, particularly for the treatment of cerebropathies of dysmetabolic and/or toxic origin, of cognitive disorders connected with aging, of Parkinson's and Alzheimer's diseases. |
